‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews a series of posters on the topic of Parkinson’s disease (PD) presented at the 7th Congress of the European Academy of Neurology (EAN) 2021. Posters presented included real-world data on the efficacy and safety of emerging treatments for patients with PD, with a focus on opicapone (ONGENTYS®, Bial, Trofa, Portugal), a catechol-O-methyltransferase inhibitor developed to manage motor fluctuations, symptoms that severely impact patient quality of life.
EMJ Neurology 9 [Supplement 3] . 2021
November 2021
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/07/Neuro_Interview_Rascol-and--940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/Yaakov-Stern-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/Jackie-French-Interview-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/Movement-Disorder-Initial-Manifestation-of-Hereditary-Hemochromatosis-A-Case-Report-Thumbnail-940x564.jpg)